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Purpose: This study investigated the genetic basis for Usher syndrome type 1 (USH1) in four consanguineous Israeli
Arab families.
Methods: Haplotype analysis for all known USH1 loci was performed in each family. In families for which haplotype
analysis was inconclusive, we performed genome-wide homozygosity mapping using a single nucleotide polymorphism
(SNP) array. For mutation analysis, specific primers were used to PCR amplify the coding exons of the MYO7A,
USH1C, and USH1G genes including intron-exon boundaries. Mutation screening was performed with direct sequencing.
Results:  A  combination  of  haplotype  analysis  and  genome-wide  homozygosity  mapping  indicated  linkage  to  the
USH1B locus in two families, USH1C in one family and USH1G in another family. Sequence analysis of the relevant
genes (MYO7A, USH1C, and USH1G) led to the identification of pathogenic mutations in all families. Two of the identified
mutations are novel (c.1135–1147dup in MYO7A and c.206–207insC in USH1G).
Conclusions: USH1 is a genetically heterogenous condition. Of the five USH1 genes identified to date, USH1C and
USH1G are the rarest contributors to USH1 etiology worldwide. It is therefore interesting that two of the four Israeli Arab
families reported here have mutations in these two genes. This finding further demonstrates the unique genetic structure
of the Israeli population in general, and the Israeli Arab population in particular, which due to high rates of consanguinity
segregates many rare autosomal recessive genetic conditions.
Usher syndrome (USH) is the most common cause of
combined  sensorineural  deafness  and  blindness,  with  a
worldwide prevalence of 1 in 16,000 to 1 in 50,000. USH is a
recessively-inherited  disorder,  characterized  by  the
combination  of  sensorineural  hearing  loss  (SNHL)  and
retinitis pigmentosa (RP) [1]. RP is a degenerative disease of
the  retina,  characterized  by  night  blindness,  followed  by
gradual  restriction  of  the  visual  field.  Additional
ophthalmologic findings include characteristic pigmentation
of  the  midperipheral  retina,  attenuation  of  the  retinal
arterioles, and pale appearance of the optic disc [2]. Based on
the severity and progression of hearing loss, age at onset of
RP, and the presence or absence of vestibular impairment, the
majority of USH cases can be classified into one of three
clinical subtypes, the most severe of which is Usher syndrome
type 1 (USH1), characterized by profound prelingual hearing
loss, vestibular areflexia, and prepubertal onset of RP. Seven
USH1 loci (USH1B–USH1H) have been mapped, and the
causative  genes  have  been  identified  for  five  of  them
(MYO7A,  encoding  myosin  VIIA,  USH1C,  encoding
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harmonin,  CDH23,  encoding  cadherin  23,  PCDH15,
encoding protocadherin 15, and USH1G, encoding SANS)
[1].
The  Israeli  population  is  composed  of  many  ethnic
groups,  including  Jews,  Christians,  Muslims,  Bedouins,
Druze,  and  more.  Although  several  founder  mutations
underlying different USH types have been reported in the
Jewish population [3–5], the genetic basis for USH in the Arab
population has not been studied. Among Israeli Arabs, 45%
of marriages are between related spouses, half of whom are
first cousins. This high rate of consanguinity consequently
leads to increased homozygosity of rare mutant alleles in
specific families and villages [6]. Homozygosity mapping is
an efficient tool for identifying the underlying genetic defects
in such families. Here we report four consanguineous Muslim
Arab Israeli families segregating USH1. Genetic analysis led
to  the  identification  of  the  underlying  mutations  in  each
family,  including  novel  mutations  of  the  MYO7A  and
USH1G genes.
METHODS
Patients:  Members  of  four  Muslim  Arab  consanguineous
Israeli families were ascertained for this study. Family TB86
was  recruited  through  Rambam  Medical  Center  in  Haifa.
Family  TB114  was  recruited  through  Hadassah  Hebrew
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3548University Hospital in Jerusalem. Families TB63 and TB109
were recruited through Ha’emek Medical Center in Afula,
Israel. At the time of recruitment all affected individuals met
diagnostic criteria for USH1 [1] except individuals II-3 in
family TB114 and III-1 in family TB63 who had SNHL only.
In total, 22 family members participated in the study (10
affected [seven males, three females] and 11 unaffected [five
males, six females]). The study was performed in accordance
with the Declaration of Helsinki and written informed consent
was obtained from all participants. The research was approved
by  the  local  institutional  review  boards  at  each  of  the
participating medical centers and by the National Helsinki
Committee for Genetic Research in Humans.
DNA analysis: Venous blood samples were obtained using
K3EDTA vacuette tubes (Greiner Bio-One, Kremsmunster,
Austria), and genomic DNA was extracted using high salt
solution according to a standard protocol [7]. DNA samples
were PCR amplified with fluorescent dye-labeled primers
flanking microsatellite repeat markers linked to all known
USH1  loci  (Table  1).  PCR  products  were  separated  by
electrophoresis  on  an  ABI  310  Genetic  Analyzer,  and
genotypes were determined with Genescan and Genotyper
software, using a Genescan-400HD-ROX size standard (PE
Applied  Biosystems,  Foster  City,  CA).  Genome-wide
homozygosity mapping was performed using the Affymetrix
GeneChip  Human  Mapping  6.0  single  nucleotide
polymorphism (SNP) array (Affymetrix, Santa Clara, CA).
Homozygous regions were calculated using Homozygosity
Mapper [8]. For mutation analysis, specific primers were used
to PCR amplify the coding exons of MYO7A, USH1C, and
TABLE 1. MICROSATELLITE REPEAT MARKERS LINKED TO ALL KNOWN USH1 LOCI.
Locus Chromosome Gene and markers Location (MB) PCR primers for marker amplification
USH1B 11 D11S4179 76 F: GGATGTAAGAGTAACTGGCTCG
        R: GAAAATGTTCTGCCTGAGGG
    D11S1789 76.7 F: ACCAGGAAATTGAGAACCA
        R: TCTGGCCCAACAGAAGT
    D11S4079 76.8 F: CAGCAAGATCCTGTCTCAA
        R: CTCCTTAAAGTGGGGGAGTT
    MYO7A 76.8–76.9  
    D11S937 77.5 F: CTAATAAACAAATCCCTCTACCTCC
        R: TAGTCAGTCAGGGACCCAAGT
USH1C 11 D11S902 17.4 F: CCCGGCTGTGAATATACTTAATGC
        R: CCCAACAGCAATGGGAAGTT
    USH1C 17.5  
    D11S4138 17.7 F: GTGCTGACCGCTCCAAGG
        R: CCAAAGGGGTTAATAGGGGTCCA
USH1D 10 D10S537 72 F: CCTACTGTGCCTGGCTAGA
        R: ATTTGGATGAAACCCACG
    D10S606 73 F: TTTGAACCTGGGAGACG
        R: CATGGACATTCTGCTGC
    D10S1694 73.1 F: CCTGTCTGGCCCAGGTA
        R: AGTAGGGGTGCTGCTTGA
    CDH23 73.1–73.5  
USH1E 21 D21S1437 20.5 F: ATGTACATGTGTCTGGGAAGG
        R: TTCTCTACATATTTACTGCCAACA
    USH1E (locus) 19.8–31.3  
    D21S265 25.8 F: TTAAAGCAATCAATCATGG
        R: GGGTTCTGTGAATATGGG
USH1F 10 D10S2537 55.7 F: AAATGGAATATGGGGTTATTAGCA
        R: AATTATCTACATTTCCGCCACTTC
    D10S546 55.7 F: TGTGATGACTAGAAATTCAGTTCA
        R: ACTTCTCAATTACAGGCCCA
    PCDH15 55.5–56.5  
    D10S2522 56.3 F: TTTAAACACTGTCCCAACAC
        R: TGAAGGAAAGCCAAACTTA
USH1G 17 D17S1301 70.2 F: AAAGAAGATGAAATTGCCATG
        R: TAAAAAGAATGAAGGTAAAAATGTG
    D17S785 71.9 F: ATCCCTGGAGAGTGAAAATG
        R: AAGGCCAACCTGAAAACTAA
    D17S801 72 F: CCTCAAACCGGACAACTATTT
        R: CAGAGAGCAAGATCCTACCTC
    D17S937 72.8 F: CATGGAGGGACTTGCG
        R: TTCCCAGAACCCGGTTT
    USH1G 72.9  
USH1H 15 USH1H (locus) 65.1–68.4  
    D15S1015 65.6 F: TCACAGAGCGAGACCCTAT
        R: CACAGACTCAGTTTAGACAGAAATC
    D15S131 68.9 F: GAAAGGCACCTCATCTCG
        R: TTAAAAACTCTGGAGCAGCG
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3549USH1G,  including  intron-exon  boundaries.  Mutation
screening was performed by direct sequencing with the Big
Dye Terminator Cycle Sequencing Kit on an ABI 3130xl
Genetic Analyzer (PE Applied Biosystems).
RESULTS
An  USH1C  mutation  in  family  TB86:  Family  TB86  is  a
Muslim Arab family from northern Israel. The parents are first
cousins, and three of their five offspring have USH1 (Figure
1A). Bilateral profound SNHL was detected at infancy in all
three affected individuals. One manifested a delay in motor
development and walked independently at age 2.5, which is
consistent  with  the  USH1  phenotype  [1].  The  other  two
walked independently at the age of 15 months. Difficulties
with night vision were observed at a very young age, and
constriction of the visual field (VF) was detected around the
age of 10. When we examined the patients, all three were in
their 20s. They all had marked VF constriction of 20° to less
than  10°  and  nondetectable  electroretinograms  (ERG).
Funduscopic  examination  revealed  typical  retinal  bone
spicule-type pigment deposits (Table 2).
Haplotype analysis with markers linked to all known
USH1 loci indicated co-segregation of a haplotype of two
polymorphic marker alleles (D11S902 and D11S4138) linked
to the USH1C locus on chromosome 11p15.1 with USH1 in
this family (Figure 1A). Sequence analysis of the 27 coding
exons of the USH1C gene, including exon-intron boundaries,
revealed a deletion of an A nucleotide at position −2 of intron
5, within the conserved acceptor splice-site (c.497–2delA)
(Figure 2A). Analysis of all available family members showed
that the mutation co-segregated with USH1 in this family:
Affected  individuals  were  homozygotes  for  the  mutation,
while their parents were heterozygotes (Figure 1A). The c.
497–2delA mutation was previously reported as IVS5–2delA
in two unrelated families from Lebanon [9].
A MYO7A mutation in family TB114:   Family TB114 is  a
Muslim Arab family from the Jerusalem area. The parents are
first cousins, and two of their three offspring, who were seen
by us at the ages of 8 years and 8 months, have bilateral
profound SNHL, which was detected at infancy. The affected
daughter received a cochlear implant in one ear with very good
results. She was recently diagnosed with RP. The affected son
is a young baby, and RP has not been diagnosed yet (Figure
1B and Table 2).
Haplotype analysis with markers linked to all known
USH1 loci was only partially informative, and the results were
non-conclusive.  We  therefore  performed  genome-wide
homozygosity  mapping  using  the  Affymetrix  GeneChip
Human  Mapping  6.0  SNP  array.  A  shared  homozygous
interval of 57 Mb, composed of 15,470 consecutive SNPs on
Figure 1. Pedigrees and genotypes of
Israeli Arab families with USH1. Shown
are  four  Israeli  Arab  families
segregating  USH1.  Double  lines
indicate consanguineous unions. Filled
symbols represent affected individuals,
whereas  clear  symbols  represent
unaffected  individuals.  Mutation-
bearing  haplotypes  are  marked  with
black bars. A: Family TB86. Genetic
analysis demonstrates co-segregation of
an  USH1C-linked  haplotype  and
mutation (c.497–2delA) with USH1. B:
Family  TB114.  Genetic  analysis
demonstrates  co-segregation  of  a
mutation  of  MYO7A  (p.Q234X)  with
USH1.  C:  Family  TB63.  Genetic
analysis demonstrates co-segregation of
an  USH1B-linked  haplotype  and  a
MYO7A  mutation  (c.1135–1147dup)
with USH1. D: Family TB109. Genetic
analysis demonstrates co-segregation of
a mutation of USH1G (c.206–207insC)
with  USH1.  m,  mutant  allele;  +,  wt
allele.
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3551chromosome 11p13-q14.3, was identified in both affected
individuals. This interval contains the gene underlying the
USH1B locus, MYO7A. Sequence analysis of the 49 coding
exons  of  MYO7A,  including  exon-intron  boundaries,  was
performed  in  the  affected  daughter.  We  identified  a
homozygous C to T transition that generates a premature stop
codon, located in exon 7 (c.700C>T; p.Q234X) (Figure 2B).
Analysis of all available family members revealed that the
mutation  co-segregated  with  the  disease  in  this  family:
Affected  individuals  were  homozygotes  for  the  mutation,
while  their  parents  and  their  unaffected  brother  were
heterozygotes (Figure 1B). The p.Q234X mutation has been
reported  previously  in  compound  heterozygosity  with  a
second MYO7A mutation (c.3750+2T>A) in an USH1 patient
of unknown ethnicity [10].
A novel MYO7A mutation in family TB63: Family TB63 is a
Bedouin family from northern Israel. The parents are first
cousins,  and  two  of  their  eight  offspring  (Figure  1C,
individuals  II-1  and  II-3)  have  bilateral  profound  SNHL,
which was detected at infancy. The affected daughter received
a cochlear implant at the age of 2. Both were diagnosed with
RP at the age of 9 (Table 2).
Haplotype analysis with markers linked to all known
USH1 loci indicated co-segregation of a haplotype of four
polymorphic  marker  alleles  (D11S4179,  D11S1789,
D11S4079, and D11S937) linked to the USH1B locus on
chromosome 11q13.5 with USH1 in this family (Figure 1C).
Sequence analysis of the 49 coding exons of the MYO7A gene,
including  exon-intron  boundaries,  was  performed  in  the
affected son. We identified a homozygous 13 bp duplication
in exon 11 (c.1135–1147dup; Figure 2C). This novel mutation
is expected to lead to a frameshift and premature termination
of translation after insertion of 63 irrelevant amino acids,
starting  at  position  383  of  the  myosin  VIIA  protein
(p.S383WfsX63). Analysis of all available family members
revealed that the mutation co-segregated with USH1 in this
family:  Affected  individuals  were  homozygotes  for  the
mutation,  while  their  parents  and  two  of  their  unaffected
siblings  were  heterozygotes  (Figure  1C).  The  c.1135–
1147dup  mutation  was  not  identified  among  100
chromosomes  derived  from  ethnically-matched  normal
controls.
Five years after we first saw the family, the affected son
married a healthy woman, with normal vision and hearing
(Figure 1C, individuals II-1 and II-2, respectively). The two
were not related to each other; nevertheless, since they were
from the same village, we tested the wife for the c.1135–
1147dup mutation, which was identified in her husband. She
was found to carry two normal copies of MYO7A exon 11. A
year later, the couple had a son (Figure 1C, individual III-1).
He was diagnosed shortly after birth with severe SNHL. Since
he is a young baby, his visual function has not been evaluated
yet. Sequencing of MYO7A exon 11 revealed that, as expected,
he was heterozygote for the c.1135–1147dup mutation. We
hypothesized that he may be a compound heterozygote for c.
1135–1147dup and a second MYO7A mutation, which was
either inherited from his mother or generated de novo. We
therefore  sequenced  all  coding  exons  of  MYO7A  in  this
individual, and found several known polymorphisms but no
additional mutations. Sequencing of the single coding exon of
GJB2 (encoding connexin 26), the most common cause for
hereditary hearing loss worldwide [11], revealed no mutations
either.
A novel USH1G mutation in family TB109: Family TB109
(Figure 1D) is a Bedouin family from northern Israel. The
parents are first cousins, and their two sons have bilateral
profound SNHL, which was detected at infancy. Both sons
received cochlear implants. They have developmental delay,
balance  problems,  and  behavioral  problems.  RP  was
diagnosed when the sons were ages of 3 and 5. When we saw
the sons, at the ages of 8 and 6, both had reduced visual acuity
(BE:  6/10  and  BE:  6/12,  respectively).  Funduscopic
examination  revealed  extensive  salt  and  pepper–like
degeneration with mild vascular attenuation, a reduced foveal
reflex, and normal optic discs. There were no bone spicules
or pigment deposits, although these may appear by the end of
the  second  decade  of  life  (Figure  3).  Macular  optical
coherence tomography was normal (data not shown; Table 2).
Haplotype analysis with markers linked to all known
USH1 loci was only partially informative, and the results were
non-conclusive.  We  therefore  performed  genome-wide
homozygosity  mapping  using  the  Affymetrix  GeneChip
Human  Mapping  6.0  SNP  array.  A  shared  homozygous
interval of 7 Mb, composed of 2,224 consecutive SNPs on
chromosome  17q25.1,  was  identified  in  both  affected
individuals. This interval contains the USH1G gene. Sequence
analysis of the three coding exons of USH1G, including exon-
intron boundaries, was performed in one affected son. We
identified a homozygous insertion of a C nucleotide between
positions 206 and 207 of USH1G cDNA, located in exon 2 (c.
206–207insC; Figure 2D). This novel mutation is expected to
lead to a frameshift and premature termination of translation
after insertion of 66 irrelevant amino acids, starting at position
69 of the SANS protein (p.L69PfsX66). Analysis of other
available  family  members  revealed  that  the  mutation  co-
segregated  with  USH1  in  this  family:  Both  affected
individuals were homozygotes for the mutation, and their
parents are heterozygotes (Figure 1D). The c.206–207insC
mutation was not identified among 98 chromosomes derived
from ethnically-matched normal controls.
DISCUSSION
In this study, we identified USH1-causing mutations in four
Israeli Muslim Arab families. Of the four mutations identified
in these families, two have been reported before. One, the c.
497–2delA mutation of USH1C, found in family TB86, was
Molecular Vision 2011; 17:3548-3555 <http://www.molvis.org/molvis/v17/a381> © 2011 Molecular Vision
3552previously identified in affected members of two Lebanese
families  [9].  Based  on  the  common  ethnicity  (Arab)  and
relative geographic proximity (Lebanon and northern Israel),
the  three  families  may  share  a  common  ancestry.  The
p.Q234X mutation of MYO7A, found in family TB114, has
been  reported  previously  in  a  USH1  patient  of  unknown
ethnicity [10,12]. This individual may be related to family
TB114; alternatively, p.Q234X may be a recurrent mutation.
In family TB109, we identified a novel USH1G mutation
(c.206–207insC), which brings the total number of USH1G
Figure  2.  USH1C,  MYO7A,  and  USH1G  mutations  identified  in
Israeli Arab families. For each mutation, sequence chromatograms
are shown for a non-carrier individual (wt) and an affected individual
homozygous  for  the  mutant  allele  (mut).  A:  The  c.497–2delA
mutation  of  USH1C.  The  exon-intron  boundary  is  marked.  The
deleted base is marked with an arrow on the wt trace. B: The c.
700C>T (p.Q234X) mutation of MYO7A. The mutant base is marked
with an arrow. C: The c.1135–1147dup mutation of MYO7A. The
duplicated sequence is marked with a box. D: The c.206–207insC
mutation of USH1G. The inserted base is marked with an arrow.
mutations reported to date to eight. Six of these have been
associated  with  a  typical  USH1  phenotype,  including
congenital profound SNHL and prepubertal onset of RP. They
include five truncating mutations (c.829–848del, c.393insG,
c.186–187delCA,  p.W38X,  and  c.206–207insC)  and  one
missense  mutation  (p.L48P)  that  appeared  in  compound
heterozygosity  with  c.186–187delCA  ([13,14]  and  current
report).  Notably,  two  novel  mutations  of  USH1G  were
recently reported in individuals with atypical Usher syndrome
(p.D458V and c.163_164+13del15). Homozygotes for each
mutation had congenital moderate to profound SNHL, normal
Figure 3. Fundus photographs of affected individuals from family
TB109. Fundus photographs of individual II-1 at the age of 8 (A),
and individual II-2 at the age of 6 (B), demonstrating extensive retinal
degeneration,  salt  and  pepper–like,  retinal  pigment  epithelial
atrophy, reduced foveal reflex, irregularity of vitreoretinal interface,
mild vascular attenuation, and absence of peripheral bone spicules
or pigment deposits. The optic disc looks normal with no definitive
pallor or signs of atrophy.
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3553vestibular function, and mild RP. One is a missense mutation
(p.D458V) involving the PDZ binding motif of the SANS
protein,  and  is  predicted  to  reduce  the  strength  of  its
interaction  with  harmonin,  the  protein  encoded  by  the
USH1C  gene  [15].  Interestingly,  the  other  one  (c.
163_164+13del15A) involves nucleotides in the first exon
and the first intron of the USH1G gene, and is expected to lead
to aberrant splicing and generation of a truncated protein
[16]. These findings indicate that missense and truncating
mutations of USH1G can result in a milder USH phenotype,
and that the severity of the phenotype induced by USH1G
mutations  may  be  modified  by  unknown  genetic  or
environmental factors [16].
Of the ten patients described here, eight are deaf and have
RP. The two patients who are only deaf are both young babies,
and therefore their retinal function has not been evaluated yet.
In USH1, deafness is congenital while the onset of RP occurs
within the first decade of life. Individual II-3 in family TB114
is homozygous for the same MYO7A nonsense mutation as his
older sister, who is deaf and has RP, and he will probably
develop RP in the future. As for individual III-1 in family
TB63,  the  situation  is  more  complex.  This  baby  is
heterozygous for the MYO7A mutation that causes USH1 in
his homozygous father and aunt, but we were not able to
identify a second MYO7A mutant allele. Several explanations
are possible for deafness in this child: he may carry a second
MYO7A mutation located within an intron or in a regulatory
region, which therefore we failed to detect; alternatively, his
deafness  may  be  due  to  mutation(s)  in  a  different  gene
(independent  segregation  of  mutations  in  more  than  one
deafness-causing  gene  within  the  same  family  has  been
previously reported [4]). A third possibility is that deafness in
this individual is due to a non-genetic etiology, as genetics
accounts for only about 50% of congenital deafness cases
[17]. Whether this individual develops RP depends on the
nature  of  his  deafness  (genetic  versus  environmentally-
caused), and of the additional mutation(s) he carries (if at all),
and cannot be predicted at this stage.
USH1 is a genetically heterogenous condition. Seven
USH1 loci have been mapped, and the causative genes have
been  identified  for  five  [1].  As  of  September  2011,  655
different  mutations  for  USH1  are  listed  in  the  UMD-
USHbases,  a  comprehensive  set  of  databases  that  records
pathogenic mutations and unclassified variants in seven USH-
causing genes [18]. Of these, 52% are in the MYO7A gene,
followed by CDH23 (28%), PCDH15 (13%), USH1C (6%),
and USH1G (1%). As indicated by these numbers, USH1C
and  USH1G  are  the  rarest  contributors  to  USH1  etiology
worldwide. Mutations of USH1C are a rare cause of USH1,
except in the Acadian population, which segregates a founder
mutation in this gene [13,19,20]. For USH1G, only seven
mutations have been reported to date [13–16]. It is therefore
interesting that two of the four Israeli Arab families reported
here have mutations in these two genes. This finding further
demonstrates  the  unique  genetic  structure  of  the  Israeli
population  in  general,  and  the  Israeli  Arab  population  in
particular, which due to high rates of consanguinity segregates
many rare autosomal recessive genetic conditions [6].
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